Skip to main content
Funded Studies

Matthew Allister Cooper, PhD

CEO at Inflazome Ltd

Location: Dublin Ireland

Matthew Cooper, PhD, is a translational medical researcher and entrepreneur with expertise in diagnostics, drug discovery and the development of anti-microbial and anti-inflammatory therapies. He has founded four biotechnology companies with multiple products licensed or on the market. He also holds a fractional Professorial Research Fellow appointment at the University of Queensland, Australia, and at Trinity College Dublin, Ireland. He is a fellow of the Royal Society of Medicine and a member of the Royal Society of Chemistry.

Associated Grants

  • PET Tracer to Support Trials of Drugs Inhibiting Neuroinflammation via the NLRP3 Inflammasome


  • Blocking Inflammasome-induced Neuroinflammation in Parkinson's Disease with a Potent, Orally Available Small Molecule


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.